Top Markets
#1 GALA GALA +32.47%
#2 Fabric Protocol Fabric Protocol +32.28%
#3 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +31.50%
#4 Bitcoin Cash Bitcoin Cash +31.11%
#5 Tutorial Tutorial +30.85%
#6 Zora Zora +24.99%
#7 Arowana Arowana +22.89%
#8 aPriori aPriori +22.63%
#9 Talus Network Talus Network +22.63%
#10 Useless Coin Useless Coin +22.42%
Coin of the day
GALA GALA
設定
言語
日本
通貨
USD
テーマ
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
株式のランク #24695
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
株価
$0.95011029
最終同期: 2023-06-28
時価総額
$57.72M
変化（1日）
8.53%
変化（1年）
0.00%
国
FR
取引 ERYTECH Pharma S.A. (ERYP)

カテゴリー

Healthcare
ERYTECH Pharma S.A.（ERYP）の配当利回りの履歴
ERYTECH Pharma S.A.（銘柄コード: ERYP）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
ERYTECH Pharma S.A.（ERYP）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH